JCG
AMED

JHL Capital Group’s Amedisys AMED Stock Holding History

JHL Capital Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-905,000
Closed -$18.3M – 20
2014
Q3 		$18.3M Sell
905,000
-145,000
-14% -$2.8M 0.99% 15
2014
Q2 		$17.6M Buy
1,050,000
+450,000
+75% +$6.38M 0.85% 18
2014
Q1 		$8.93M Buy
+600,000
New +$9.23M 0.63% 21

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHL Capital Group's AMED Position: Q4 2014 in Review

JHL Capital Group sold out of Amedisys (AMED) in Q4 2014, closing a stake of 905,000 shares — an estimated $18.3M sold.

JHL Capital Group first reported a position in AMED in Q1 2014 and held it in 3 quarters. The position peaked at $18.3M in Q3 2014. 137 funds tracked by Wall St. Rank hold AMED as of Q4 2014.

  • JHL Capital Group reported no remaining Amedisys position as of Q4 2014 after selling out during the quarter.
  • JHL Capital Group sold 905,000 Amedisys shares in Q4 2014, an estimated $18.3M.
  • JHL Capital Group first reported a position in Amedisys in Q1 2014 and held it in 3 quarters.
  • JHL Capital Group's Amedisys position peaked at $18.3M in Q3 2014.
  • 137 funds tracked by Wall St. Rank held Amedisys as of Q4 2014.

Based on JHL Capital Group's 13F filing for Q4 2014, filed 17 Feb 2015.